Guangdong hybribio biotech (300639.SZ): Has not yet initiated the first buyback.

Gelonghui, December 2nd丨Guangdong Hybribio Biotech (300639.SZ) announced that as of November 30, 2024, the company has not yet initiated the first share repurchase through centralized bidding in the third repurchase of shares for 2024.

Gelonghui FinanceDec 2 18:41

Guangdong Hybribio Biotech (300639.SZ): The company and its subsidiaries have obtained a grant for 1 invention patent.

Gelonghui December 2nd | guangdong hybribio biotech (300639.SZ) announced that the company and its subsidiaries were granted one invention patent in November 2024, with the invention patent titled a method for isolating trophoblast layer cells from cervical shed cells of pregnant women. The invention patent discloses a method for isolating trophoblast layer cells from cervical shed cells of pregnant women, which is based on the specific antigens and combinations expressed on the surface or inside of trophoblast cells, and utilizes a designed microfluidic sorting chip or flow cytometer to sort the cell suspension prepared from the cervical shed cells of pregnant women, thereby obtaining purified placental cells.

Gelonghui FinanceDec 2 16:04

Hybribio Biotech to Apply for 70 Million Yuan for Share Buyback Plan

MT NewswiresNov 20 17:30

Express News | Guangdong Hybribio Biotech: signed a 70 million yuan share buyback loan contract.

BreakingsNov 19 16:52

Express News | This week, 35 listed companies announced the disclosure of repurchase, shareholding, and refinancing situations. Eastern Shenghong shareholders plan to increase their holdings by up to 4 billion using their own funds and special loans.

BreakingsNov 17 17:48

Express News | guangdong hybribio biotech: planning to repurchase shares with 50 million yuan to 0.1 billion yuan.

BreakingsNov 14 20:19